处方模式在儿科补充性腺炎中
Hannah Neimy1,2, Courtney L Walker3, Lara Wine Lee3
1College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Pediatric dermatology
|December 18, 2025
概括
治疗儿科补充性腺炎 (HS) 的方法因疾病的严重程度而异. 更严重的HS病例 (Hurley III阶段) 比较轻微的病例 (Hurley I阶段) 更频繁地接受生物药物,内伤类固醇和疼痛管理.
科学领域:
- 皮肤病学 皮肤病学
- 儿科医学 儿科医学
- 炎症性疾病 炎症性疾病
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病.
- 儿科患者诊断率的增加凸显了了解治疗模式的必要性.
- 关于特别针对儿童和青少年的HS治疗实践的数据有限.
研究的目的:
- 根据疾病的严重程度,分析儿科辅助性水炎的治疗变化.
- 为了确定在严重的儿科HS病例中更常用的特定疗法.
主要方法:
- 这是一项回顾性研究,分析了163名被诊断为HS的儿科患者 (年龄≤18岁) 的数据.
- 疾病的不同Hurley阶段 (I,II,III) 治疗方法的比较.
- 基于疾病严重程度的统计分析,以确定治疗模式的显著差异.
主要成果:
- 儿科HS的治疗模式与疾病严重程度 (Hurley阶段) 有显著的相关性.
- 与Hurley III期HS患者相比,与Hurley I期HS患者相比,患者更有可能接受生物药物,赫西丁,内伤类固醇,甲福明,口服类固醇和螺旋.
- 更高的Hurley阶段与增加治疗疼痛的处方有关,包括NSAID和阿片类药物.
结论:
- 疾病的严重程度是治疗选择的关键决定因素,在儿科辅助性腺炎.
- 在更严重的儿科HS病例中,使用了更积极的疗法和疼痛管理.
- 进一步的研究是有必要的,以优化儿童患者的HS管理策略.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
01:23Hand hygiene
5.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
5.4K
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
230
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
230
01:29Drug Dosing: Infants and Children
231
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240